Malignant Hypopharyngeal Neoplasm — Trials

Malignant Hypopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

191 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 53
Recruiting: 31
Ph III recruiting: 5
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.4%
Trials / 1,000 deaths: 109.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05860335	Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer	unknown	Phase 2	30	Chinese PLA General HospitalOTHER	1	Feb 20, 2024	clinicaltrials
NCT04156698	Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma	unknown	Phase 2	51	Eye & ENT Hospital of Fudan UniversityOTHER	1	Aug 9, 2023	clinicaltrials